Cargando…
Lumican modulates adipocyte function in obesity-associated type 2 diabetes
Obesity-associated type 2 diabetes (DM) leads to adipose tissue dysfunction. Lumican is a proteoglycan implicated in obesity, insulin resistance (IR), and adipocyte dysfunction. Using human visceral adipose tissue (VAT) from subjects with and without DM, we studied lumican effects on adipocyte funct...
Autores principales: | Strieder-Barboza, Flesher, Carmen G., Geletka, Lynn M., Eichler, Tad, Akinleye, Olukemi, Ky, Alexander, Ehlers, Anne P., Lumeng, Carey N., O’Rourke, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728465/ https://www.ncbi.nlm.nih.gov/pubmed/36457256 http://dx.doi.org/10.1080/21623945.2022.2154112 |
Ejemplares similares
-
Depot-specific adipocyte-extracellular matrix metabolic crosstalk in murine obesity
por: Strieder-Barboza, Clarissa, et al.
Publicado: (2020) -
Matrix density regulates adipocyte phenotype
por: Ky, Alexander, et al.
Publicado: (2023) -
Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes
por: Russo, Lucia, et al.
Publicado: (2020) -
Obesity results in adipose tissue T cell exhaustion
por: Porsche, Cara E., et al.
Publicado: (2021) -
The human type 2 diabetes-specific visceral adipose tissue proteome and transcriptome in obesity
por: Carruthers, Nicholas J., et al.
Publicado: (2021)